FirmAtlas

Company handbook · ALB · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-17

ALB · CIK 915913 · LATEST FILING: 10-Q JUN '26 · FILED AUG 5, 2026

ALBEMARLE CORPORATION

$95.48 −2.70 (−2.75%)

Close, Oct 16, 2026 · 52-week $88–221

↗ albemarle.com

Last fiscal year

ALBEMARLE CORPORATION reported revenue of $5.1B for the year ended Dec 31, 2025 (FY25), down 4.4% from FY24. Net loss was $511M, operating cash flow $1.3B and free cash flow $692M. Source: 10-K filed Feb 11, 2026.

Market cap

$11.2B

P/E

50.1

EV/EBITDA

44.2x

P/B

1.1

Div yield

1.70%

ROIC

−3.1%

Revenue 1Y

−4.4%/yr

EPS 1Y

n/m

Shares 1Y

+0.1%

Loading chart…

Daily closes, split-adjusted · ratios at each fiscal year end

Company

CEOJ. Kent Masters, Jr.

HQCharlotte, NC

AuditorPricewaterhouseCoopers LLP

Employees7,800

Year endsDecember

Revenue by segment · FY25

Energy Storage53%

Specialties27%

Catalysts21%

Compounded growth & averages

10Y

TTM

Share price

1.7%

−16.0%

−17.1%

0.2%

Upgrade to see 10 years

Share price: yearly compound rate of the traded close; the last column is the past year.

Where the cash went · FY24–FY25

$2.6B deployed

Capex $2.3B 85.7%

Dividends $379M 14.3%

Operating cash flow over the period: $2.0B. Total debt changed by −$647M. R&D of $138M is already inside operating costs.

Sources 10-K FY25 10-Q Jun '26 All filings on EDGAR

Latest filings

Sep 3, 2026 Executive or director change 8-K Aug 21, 2026 Executive or director change 8-K Aug 5, 2026 Quarterly results 8-K Jul 23, 2026 Executive or director change 8-K Jun 5, 2026 Executive or director change 8-K

Growth engines

How much of the profit growth came from new investment, and how much from running the business better.

Upgrade to see 10 years

Financials

Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · change vs previous year

Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier

TTM = the last four quarters, to Jun '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.

Income

FY24 FY25

TTM

Revenue

5,378

5,143−4.4%

5,908

YoY

−4.4%

Gross profit

669+969.3%

1,407

Gross margin

1.2%

13.0%+11.8 pp

—

Operating income

(1,777)

(367)n/m

252

Operating margin

−33.0%

−7.1%+25.9 pp

—

EBITDA

(1,188)

292n/m

—

EBITDA margin

−22.1%

5.7%+27.8 pp

—

Interest expense

166

208+25.4%

—

Interest coverage

−7.17x

1.40x+8.58x

—

Net income

(1,179)

(511)n/m

224

YoY

n/m

Net margin

−21.9%

−9.9%+12.0 pp

—

EPS (diluted, $)

−11.20

−5.76n/m

—

YoY

n/m

Balance sheet

FY24 FY25

TTM

Total assets

16,610

16,374−1.4%

15,905

Cash & short-term investments

1,192

1,618+35.7%

—

Accounts receivable

742

594−20.0%

—

Inventory

1,503

1,179−21.5%

—

Net PP&E

9,331

8,612−7.7%

—

Other assets

3,841

4,371+13.8%

—

Total liabilities

6,648

6,841+2.9%

5,630

Total debt

3,914

3,268−16.5%

1,951

Other liabilities

2,734

3,573+30.7%

—

Shareholders’ equity

9,962

9,533−4.3%

10,275

Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.

Cash flow statement · as filed

FY24 FY25

TTM

Cash from operations

688

1,282+86.4%

1,800

Net income

(1,135)

(465)n/m

—

Depreciation & amortization

589

659+11.9%

—

Stock-based compensation

40+25.3%

—

Working capital & other

1,203

1,049−12.8%

—

Cash from investing

(1,585)

(146)n/m

—

Capex

(1,681)

(590)n/m

—

PP&E sold

33+12.7%

—

Investments sold / matured

291n/m

—

Other investing

120+80.1%

—

Cash from financing

1,242

(834)−167.2%

—

Debt raised

112

57−49.5%

—

Debt repaid

(112)

(506)n/m

—

Dividends

(189)

(191)n/m

—

Shares issued

0.4

3+766.3%

—

Other financing

1,430

(198)−113.8%

—

Net change in cash

302

426+40.8%

—

Free cash flow (OCF − capex)

(993)

692n/m

1,342

Where the cash went

FY24 FY25

TTM

Operating cash flow

688

1,282+86.4%

1,800

Reinvested in the business

1,681

590−64.9%

—

% of operating cash flow

244.3%

46.0%

Capex

1,681

590−64.9%

458

R&D (memo, already in costs)

51−40.7%

—

Free cash flow

(993)

692n/m

1,342

YoY

n/m

Returned to shareholders

189

191+1.1%

—

% of free cash flow

—

27.5%

Dividends

189

191+1.1%

—

Change in total debt

—

(647)

—

Cash left over

—

(145)

—

Owner earnings

—

Owner earnings margin

—

0.6%

—

Returns & ratios

FY24 FY25

TTM

ROIC (all capital)

−14.0%

−3.1%+10.9 pp

—

ROIC (operating)

−15.3%

−3.3%+12.0 pp

—

Net debt / EBITDA

—

5.66x

—

Debt / equity

0.39x

0.34x−0.05x

—

ROE

−11.8%

−5.4%+6.5 pp

—

ROA

−7.1%

−3.1%+4.0 pp

—

ROCE

−12.1%

−2.5%+9.6 pp

—

NOPAT

(1,777)

(367)n/m

—

Invested capital (operating)

11,576

10,385−10.3%

—

Invested capital (all)

12,683

11,183−11.8%

—

Reinvestment rate

—

324.5%

—

Debtor days

42−8 d

—

Inventory days

103

96−7 d

—

Net debt is 5.7x EBITDA (FY25).

Income

Sep '25

Dec '25

Mar '26

Jun '26

Revenue

1,308

1,428

1,429

1,743

vs year-ago quarter

Gross profit

118

198

501

590

Gross margin

9.0%

13.9%

35.1%

33.9%

Operating income

(217)

234

453

Net income

(161)

(414)

319

480

vs year-ago quarter

Net margin

−12.3%

−29.0%

22.3%

27.5%

EPS (diluted, $)

−1.72

−3.52

2.34

3.52

vs year-ago quarter

Balance sheet

Sep '25

Dec '25

Mar '26

Jun '26

Total assets

17,148

16,374

15,140

15,905

Cash & equivalents

1,932

1,618

1,090

1,632

Total debt

4,072

3,268

1,956

1,951

Shareholders’ equity

9,996

9,533

9,850

10,275

Cash flow

Sep '25

Dec '25

Mar '26

Jun '26

Operating cash flow

356

388

346

710

Capex

132

155

Free cash flow

223

233

248

638

vs year-ago quarter